Associate Professor, Harvard Medical School
Radiation Oncologist, Brigham and Women’s Hospital

Dr. Viswanathan is a board certified radiation oncologists and Associate Professor at Harvard Medical School. Dr. Viswanathan specializes in gynecologic malignancies and image-guided brachytherapy. At the Dana-Farber/Brigham and Women’s, she led the development and growth of the gynecology practice and designed clinical trials of real-time MRI-based image-guided brachytherapy and CT-based imaging for gynecologic cancer patients. She implemented the first use of IMRT techniques at the Dana-Farber/Brigham and Women’s for selected gynecologic cancer patients. In addition to clinical outcomes, Dr. Viswanathan’s research focuses on risk factors and prevention of endometrial cancer.  She is actively involved in protocol development, serving as principal investigator for an accruing trial, and works with the Radiation Therapy Oncology Group Gynecology Steering Committee to study novel therapeutics in gynecologic cancers.

Assistant Professor of Radiation Oncology
University of Colorado School of Medicine

Dr. Fisher is a board certified Assistant Professor in the Department of Radiation Oncology at University of Colorado. Dr. Fisher is an active member of the University of Colorado’s Breast Center and Multidisciplinary Breast Cancer Clinic, as well as in many professional organizations including the American Society for Radiation Oncology (ASTRO), American Brachytherapy Society (ABS), American Society for Clinical Oncology (ASCO), and Alpha Omega Alpha Medical Honor Society (AOA). She has published numerous scientific articles and regularly presents her research at national and international scientific meetings. She currently serves as Medical Student Program Director and Associate Residency Program Director for the Department of Radiation Oncology.

Vice Chair and Professor of Radiation Oncology at the University of Utah
Senior Director for Clinical Research at the Huntsman Cancer Institute

David Gaffney’s main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma. Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.

Professor, Department of Radiation Oncology
Division of Radiation Oncology
The University of Texas MD Anderson Cancer Center, Houston, TX

Dr. Anuja Jhingran earned her M.D. at Texas Tech University in 1988, followed by residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology. She began her career as an Assistant Professor at The University of Texas MD Anderson Cancer Center in 1996 and has grown and advanced to Professor of Radiation Oncology in the Section of Gynecology. She is a physician specializing in the treatment of gynecologic cancers. Clinically, she is interested in the management of advanced ovarian, cervical, and endometrial cancers and the use of advanced radiation techniques to minimize toxicity. In addition, Dr. Jhingran is heavily involved with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG), in the development of patient care studies to treat gynecologic cancers and has been the national Principal Investigator of several studies, including a phase III study in cervical cancer. Dr. Jhingran is also an active member of the Gynecologic Cancer InterGroup. Dr. Jhingran travels extensively internationally for cancer education. She is passionate about women’s health issues and especially as it relates to developing country’s efforts to establish improved healthcare for the general populace, not just the financially able.